SCHEMBL8779715

SCHEMBL8779715

Cc1nc(-c2cccc(Cc3ccc(Cl)cc3)n2)nc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPK1 P28482 1/20 0.44
PDE10A Q9Y233 1/20 0.42
PDE5A O76074 1/20 0.41
APP P05067 2/20 0.40
ATM Q13315 1/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
METAP1 P53582 1/20 0.38
CYP1A2 P05177 2/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
USP1 O94782 1/20 0.38
WDR48 Q8TAF3 1/20 0.38
PRNP P04156 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779392 0.91 PDE10A (0.46) L3MBTL1PDE10APDE5AALDH1A1SMN1; SMN2
SCHEMBL8779574 0.84 MAPK1 (0.62) MAPTL3MBTL1MAPK1PDE5AATM
SCHEMBL14733012 0.79 PDE10A (0.47) MAPTL3MBTL1PDE10AALDH1A1SMN1; SMN2
SCHEMBL8779730 0.78 PDE10A (0.40) MAPK1PDE10AALDH1A1CYP1A2CYP3A4
SCHEMBL8778144 0.77 USP1 (0.39) MAPTL3MBTL1MAPK1PDE5ASMN1; SMN2
SCHEMBL8779457 0.75 SMN1; SMN2 (0.41) L3MBTL1PDE5AALDH1A1SMN1; SMN2METAP1
SCHEMBL9607741 0.75 BRD4 (0.40) MAPTL3MBTL1PDE5AALDH1A1SMN1; SMN2
SCHEMBL3787489 0.74 MAPT (0.50) MAPTL3MBTL1MAPK1PDE5AATM
SCHEMBL28586067 0.74 MAPT (0.57) MAPTL3MBTL1MAPK1PDE10AAPP
SCHEMBL14732922 0.73 TGFBR1 (0.47) PDE10AALDH1A1CYP1A2HPGDNUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069652-A2 FUNGICIDE MIXTURES SYNGENTA PARTICIPATIONS AG (CH) 2012-05-31 WO disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 MAPT 3067/4885L3MBTL1 3069/4885MAPK1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.